
- Consultant for Pediatricians Vol 8 No 8
- Volume 8
- Issue 8
Erythema Toxicum
Erythematous pustules and papules with some coalescence developed on the anterior trunk and to a lesser degree on the face and extremities of a newborn boy the day after birth. The baby was born at full term after an uncomplicated pregnancy and delivery.
Erythematous pustules and papules with some coalescence developed on the anterior trunk and to a lesser degree on the face and extremities of a newborn boy the day after birth. The baby was born at full term after an uncomplicated pregnancy and delivery.
These lesions are characteristic of erythema toxicum. This benign, asymptomatic macular rash of unknown etiology may present with or without pustules and papules within the first few days of life in full-term infants, or within the first 2 weeks of life in premature infants. The incidence varies and may increase with gestational age. Lesions may occur anywhere on the body, except the palms and soles. The rash may wax and wane but is self-limited; it typically resolves within 2 weeks-as it did in this infant.
Diagnosis is generally based on the appearance of the rash. The differential diagnosis includes congenital infections, pyoderma, candidiasis, herpes simplex, transient neonatal pustular melanosis, milia, and miliaria. Of these, it is most important to rule out herpes simplex. Any neonatal lesion of a vesicular nature warrants closer observation.
Parental reassurance is the only treatment necessary.
Articles in this issue
about 16 years ago
Lesions That Point to Serious Bacterial Infectionsabout 16 years ago
Isolated Macrodactylyabout 16 years ago
Fish Tapeworm Infestationabout 16 years ago
Persistent Ankle Mass in an Otherwise Healthy 9-Year-Old Girlabout 16 years ago
Practical Barriers to Adolescent Confidentiality: Can They Be Overcome?about 16 years ago
When Johnny Can’t Sleepabout 16 years ago
Diagnostic Challenges Associated With Pediatric Tuberculosis: 2 CasesNewsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.














